Ariad Pharmaceuticals (ARIA)
Create an AlertAriad Pharmaceuticals News
ARIAD Honored with Gold Stevie® Awards as Pharmaceutical Company of the Year at 2013 American Business Awards
Business Wire Jun 18ARIAD Pharmaceuticals, Inc. today announced that it was honored with two Gold Stevie® Awards in the categories of Company of the Year, Pharmaceuticals and Executive of the Year, Pharmaceuticals.
Ariad's Iclusig in GIST Phase II Study - Analyst Blog
Zacks Jun 18The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase inhibitor therapy.
ARIAD Announces Webcast of Its Annual Shareholders Meeting
noodls Jun 13CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 13, 2013-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its Annual Meeting of Stockholders will be webcast live on June 20, 2013 and can be accessed ...
Ariad Pharmaceuticals Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 02:40 PM
Seeking Alpha Jun 11Ariad Pharmaceuticals Inc. Presents at Goldman Sachs 34th Annual Global Healthcare Conference, Jun-11-2013 02:40 PM
Ash Stevens to Manufacture Ponatinib API
Marketwired Jun 11Ash Stevens, Inc. , a leading provider of global contract pharmaceutical drug substance development and API manufacturing services, announces the U.S. Food and Drug Administration has approved ASI's manufacturing ...
Ariad Pharma (ARIA) Commences Iclusig Phase 2
Street Insider Jun 11ARIAD Announces Initiation of Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors
Business Wire Jun 11ARIAD Pharmaceuticals, Inc. today announced the initiation of the Phase 2 trial of Iclusig® in adult patients with metastatic and/or unresectable gastrointestinal stromal tumors .
ARIAD to Present at Upcoming Investor Conferences
Business Wire Jun 4ARIAD Pharmaceuticals, Inc. today announced that it will provide an overview of the Company’s business at two upcoming investor conferences being held next week:
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARIA | 17.21 | -0.57 | -3.23% | 3.179B |
